Project Grant HT94252310512
Award Date
9/1/23
Completion Date
8/31/27
Dollars Obligated
$902K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
This $2,794,450 federal Project Grant award from the U.S. Department of Defense's Military Medical Research and Development Program (CFDA 12.420) supports the development of an automated, rapid, high-resolution metabolic imaging system to improve management of patients with glioma brain tumors. The primary awardee, The Regents of the University of California, San Francisco (UCSF), is collaborating with Bogazici Universitesi in Turkey as a sub-grantee to develop deep learning algorithms for...
The Regents of the University of California, San Francisco will receive $1,983,742 through a three-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will support research integrating metabolic and physiologic magnetic resonance imaging (MRI) techniques for personalized glioblastoma radiotherapy planning from September 1, 2022 to August 31, 2025. Through this funding, researchers at the University of...
This federal Project Grant award in the amount of $565,250 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "ATP CITRATE LYASE AS A DRUGGABLE VULNERABILITY IN MUTANT ISOCITRATE DEHYDROGENASE GLIOMAS", will support research conducted by The Regents of the University of California, San Francisco (UCSF) from September 1, 2024 through August 31, 2027. The research aims to investigate ATP citrate...
This federal Project Grant award of $1,008,313.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support advanced biomedical research by The Regents of the University of California, San Francisco (UCSF). The award, effective September 1, 2024 through August 31, 2027, will fund UCSF's research focused on transforming healthcare for military service members and the broader public. The research aims to advance disease prevention,...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The grant funds The Regents of the University of California, San Francisco (UCSF) to conduct research across multiple medical disciplines, including cancer research, neuroscience, rare diseases,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,453,501.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2024. The grant supports the development of "Targeted Theranostic Nanopolymers for Imaging and Alpha Radiopharmaceutical Therapy of Prostate Cancer" over a period of 3 years through May 31, 2027. As a leading academic medical center, UCSF will leverage its expertise in biomedical...
This $854,219 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to translate a first-in-class PET radiotracer for assessing ferroaddiction as a therapeutic vulnerability in advanced prostate cancer. The 3-year project, running from July 2024 to June 2027, aims to develop this innovative molecular imaging approach to improve treatment selection...
The Department of the Army Medical Command awarded a $685,497 Project Grant to the Regents of the University of California, San Francisco through the Military Medical Research and Development program. The grant will fund a research project from July 2022 through July 2025 to develop GRANZYME B PET imaging as a novel method to assess T-cell activation in response to 177LU-PSMA-617 priming in metastatic castration-resistant prostate cancer. The Military Medical Research and Development program...